(Q46600594)

23 December 2017

title

R-CHOP-14 in patients with diffuse large B-cell lymphoma: feasibility and preliminary efficacy (English)

1 reference

23 December 2017

diffuse large B-cell lymphoma

1 reference

1 reference

5

1 reference

23 December 2017

Owen A O'Connor

7

object named as

Owen A O'Connor

1 reference

23 December 2017

Joachim Yahalom

8

object named as

Joachim Yahalom

1 reference

23 December 2017

Andrew D Zelenetz

9

object named as

Andrew D Zelenetz

1 reference

23 December 2017

author name string

Jeffrey L Halaas

1

1 reference

23 December 2017

Craig H Moskowitz

2

1 reference

23 December 2017

Steven Horwitz

3

1 reference

23 December 2017

Carol Portlock

4

1 reference

23 December 2017

David Straus

6

1 reference

23 December 2017

language of work or name

1 reference

1 April 2005

1 reference

23 December 2017

published in

Leukemia & Lymphoma

1 reference

23 December 2017

volume

46

1 reference

23 December 2017

issue

4

1 reference

23 December 2017

page(s)

541-547

1 reference

23 December 2017

Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190400029932

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400029932

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400029932

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400029932

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400029932

Dose-intense chemotherapy every 2 weeks with dose-intense cyclophosphamide, doxorubicin, vincristine, and prednisone may improve survival in intermediate- and high-grade lymphoma: a phase II study of the Southwest Oncology Group (SWOG 9349).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400029932

10.1080/10428190400029932

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017